Acyclovir - Revision history

Danbot: Restore original dosing content alongside dynamic SMW tables

2026-03-20T02:37:38Z

Restore original dosing content alongside dynamic SMW tables

@@ Line 5: / Line 5: @@
 ==Adult Dosing==
 ===Indications by Disease===
 {{#ask: [[Has DrugName::Acyclovir]] [[Has Population::Adult]]
-|?Treats disease=Disease
+ |?Treats disease=Disease
-|?Has Dose=Dose
+ |?Has Dose=Dose
-|?Has Context=Context
+ |?Has Context=Context
-|format=table
+ |format=table
-|limit=50
+ |limit=50
-|mainlabel=-
+ |mainlabel=-
-|headers=show
+ |headers=show
-|sort=Treats disease
+ |sort=Treats disease
 }}
 ==Pediatric Dosing==
 ===Indications by Disease===
 {{#ask: [[Has DrugName::Acyclovir]] [[Has Population::Pediatric]]
-|?Treats disease=Disease
+ |?Treats disease=Disease
-|?Has Dose=Dose
+ |?Has Dose=Dose
-|?Has Context=Context
+ |?Has Context=Context
-|format=table
+ |format=table
-|limit=50
+ |limit=50
-|mainlabel=-
+ |mainlabel=-
-|headers=show
+ |headers=show
-|sort=Treats disease
+ |sort=Treats disease
 }}

Danbot: Replace manual dosing with dynamic SMW tables (Adult + Pediatric)

2026-03-20T01:52:25Z

Replace manual dosing with dynamic SMW tables (Adult + Pediatric)

← Older revision		Revision as of 01:52, 20 March 2026
Line 5:		Line 5:

	==Adult Dosing==		==Adult Dosing==
	*[[HSV]] [[Encephalitis]]		===Indications by Disease===
	**10mg/kg IV q8h x 10 d		{{#ask: [[Has DrugName::Acyclovir]] [[Has Population::Adult]]
			\|?Treats disease=Disease
	*[[~~Herpes Simplex Virus-2\|Genital/Mucocutaneous HSV]]~~		\|?Has Dose=Dose
	**Immunocompetent		\|?Has Context=Context
	***1st episode, Mild-mod: 400mg PO TID x 7-10 d		\|format=table
	***1st episode, Severe: 5-10mg/kg IV q8h x 2-7 d		\|limit=50
	***Recurrence: ~~400mg PO TID x 5 d~~		\|mainlabel=-
	***Suppression: ~~400mg PO BID~~		\|headers=show
	**Immunocompromised		\|sort=Treats disease
	***1st episode: 400mg PO TID x 5-10 d		}}
	***Recurrence: 400mg PO TID x 5-10 d
	***Suppression: 400-800mg PO BID-TID

	*[[Varicella]]
	**Immunocompetent
	***800mg PO QID x 5-7 d
	**Immunocompromised
	***10mg/kg IV q8h x 7 d
	*Herpes Zoster
	**Immunocompetent
	***800mg PO 5x/day x 7 d
	**Immunocompromised
	***10mg/kg IV q8h x 7 d

	*[[~~Herpes Zoster~~]]
	**Immunocompetent
	***800mg PO 5x/day x 7 d
	**Immunocompromised
	***10mg/kg IV q8h x 7 d

	*[[Herpes zoster ophthalmicus]]
	**800mg PO 5x/day x 7 d

	*HSV prophylaxis in immunocompromised
	**400-~~800mg PO BID-TID~~

	*[[HSV keratitis]]
	**400mg PO 5x/day

	==Pediatric Dosing==		==Pediatric Dosing==
	*Neonatal HSV		===Indications by Disease===
	**40-60mg/kg/day IV divided q12h x 14-21 d		{{#ask: [[Has DrugName::Acyclovir]] [[Has Population::Pediatric]]
	*HSV encephalitis		\|?Treats disease=Disease
	**3 mo - 11 y/o		\|?Has Dose=Dose
	***30-45mg/kg/day IV divided q8h x 14-21 d		\|?Has Context=Context
	**>12 y/o		\|format=table
	***30mg/kg/day IV divided q8h x 14-21 d		\|limit=50
	*Genital/mucocutaneous HSV		\|mainlabel=-
	**Immunocompetent		\|headers=show
	***1st episode, 2-11 y/o		\|sort=Treats disease
	****40-80mg/kg/day PO divided q6-8 h x 5 d, max 1g/day		}}
	***1st episode, >12 y/o
	****1g/day PO divided 5x/day x 7-10 d
	**Immunocompromised
	***PO: ~~>2 y/o~~: ~~1g/day PO divided 3-5x/day x 7-14 d~~
	***IV: ~~>1 y/o: 30mg/kg/day IV divided q8h x 7-14 d~~
	*Varicella
	**Immunocompetent
	***PO: ~~> 2 y/o~~: ~~80mg/kg/day PO divided q6h x 5 d~~
	***IV: > 1 y/o: 30mg/kg/day IV divided q8h x 7-10 d
	**Immunocompromised
	***30mg/kg/day IV divided q8h x 7-10 d
	*Herpes zoster
	**Immunocompetent
	***PO: > 12 y/o: 4g/day PO divided 5x/day x 5-~~7 d~~
	***IV: 30mg/kg/day IV divided q8h x 7-10 d
	**Immunocompromised
	***30mg/kg/day IV divided q8h x 7-10 d
	*HSV-1/[[Herpes labialis]]
	**15 mg/kg PO (max dose of 200 mg) 5 times per day

	==Special Populations==		==Special Populations==

Rossdonaldson1: /* General */

2026-01-07T00:42:50Z

General

← Older revision		Revision as of 00:42, 7 January 2026
Line 1:		Line 1:
	==General==		==General==
	*Type: [[Antiviral]]: [[Is DrugClass:: nucleoside analoge]]		*Type: [[Antiviral]]: [[Is DrugClass:: nucleoside analoge]]
	*Dosage Forms: IV, PO		*Dosage Forms: IV, PO (200 mg, 400 mg, and 800 mg)
	*Common Trade Names: Zovirax		*Common Trade Names: Zovirax

Rossdonaldson1: /* Pediatric Dosing */

2026-01-07T00:40:41Z

Pediatric Dosing

← Older revision		Revision as of 00:40, 7 January 2026
Line 75:		Line 75:
	***30mg/kg/day IV divided q8h x 7-10 d		***30mg/kg/day IV divided q8h x 7-10 d
	*HSV-1/[[Herpes labialis]]		*HSV-1/[[Herpes labialis]]
	*15 mg/kg PO (max dose of 200 mg) 5 times per day		**15 mg/kg PO (max dose of 200 mg) 5 times per day

	==Special Populations==		==Special Populations==

Rossdonaldson1: /* Pediatric Dosing */

2026-01-07T00:40:29Z

Pediatric Dosing

← Older revision		Revision as of 00:40, 7 January 2026
Line 73:		Line 73:
	***IV: 30mg/kg/day IV divided q8h x 7-10 d		***IV: 30mg/kg/day IV divided q8h x 7-10 d
	**Immunocompromised		**Immunocompromised
	***30mg/kg/day IV divided q8h x 7-10 d		***30mg/kg/day IV divided q8h x 7-10 d
			*HSV-1/[[Herpes labialis]]
			*15 mg/kg PO (max dose of 200 mg) 5 times per day

	==Special Populations==		==Special Populations==

Ostermayer: /* General */

2025-08-30T13:57:49Z

General

← Older revision		Revision as of 13:57, 30 August 2025
Line 1:		Line 1:
	==General==		==General==
	*Type: [[Antiviral]]: [[Is DrugClass:: nucleoside ~~analogue~~]]		*Type: [[Antiviral]]: [[Is DrugClass:: nucleoside analoge]]
	*Dosage Forms: IV, PO		*Dosage Forms: IV, PO
	*Common Trade Names: Zovirax		*Common Trade Names: Zovirax

Ostermayer: /* General */

2025-08-30T13:37:07Z

General

← Older revision		Revision as of 13:37, 30 August 2025
Line 1:		Line 1:
	==General==		==General==
	*Type: [[Antiviral]]: ~~guanosine analog~~		*Type: [[Antiviral]]: [[Is DrugClass:: nucleoside analogue]]
	*Dosage Forms: IV, PO		*Dosage Forms: IV, PO
	*Common Trade Names: Zovirax		*Common Trade Names: Zovirax

ClaireLewis at 16:38, 19 September 2019

2019-09-19T16:38:03Z

← Older revision		Revision as of 16:38, 19 September 2019
Line 5:		Line 5:

	==Adult Dosing==		==Adult Dosing==
	*HSV [[Encephalitis]]		*[[HSV]] [[Encephalitis]]
	**10mg/kg IV q8h x 10 d		**10mg/kg IV q8h x 10 d

Line 102:		Line 102:
	==Adverse Reactions==		==Adverse Reactions==
	===Serious===		===Serious===
	*Hallucinations / psychosis		*[[Hallucinations]] / [[psychosis]]
	*[[Seizure]]		*[[Seizure]]
	*Coma		*[[Coma]]
	*Encephalopathy		*[[Encephalopathy]]
	*Thrombocytopenia		*[[Thrombocytopenia]]
	*Leukopenia		*[[Leukopenia]]
	*[[Anaphylaxis]]		*[[Anaphylaxis]]
	*Angioedema		*[[Angioedema]]
	*Erythema Multiforme		*[[Erythema Multiforme]]
	*SJS / TEN / TTP		*[[SJS]] / [[TEN]]
	*Hepatitis		*[[TTP]]
	*Renal failure		*[[Hepatitis]]
			*[[Renal failure]]

	===Common===		===Common===
Line 139:		Line 140:

	<references/>		<references/>
	[[Category:Pharmacology]]		[[Category:Pharmacology]] [[Category:ID]]

Fletc151: /* References */

2019-06-06T15:50:00Z

References

← Older revision		Revision as of 15:50, 6 June 2019
Line 92:		Line 92:
	****PD: no supplement		****PD: no supplement
	**Pediatric		**Pediatric
			**Geriatric
			***Refer to adult dosing. Oral: Initial doses should begin at the low end of the dosage range
	*Hepatic Dosing		*Hepatic Dosing
	**Not defined		**Not defined
Line 133:		Line 135:
	==References==		==References==
	*Epocrates 2015		*Epocrates 2015
			*Acetazolamide injection [prescribing information]. Big Flats, NY: X-Gen Pharmaceuticals, Inc; October 2015.
			*Acetazolamide tablets [prescribing information]. Hawthorne, NY: Taro Pharmaceuticals; September 2013.

	<references/>		<references/>
	[[Category:Pharmacology]]		[[Category:Pharmacology]]

Ostermayer: Text replacement - "Anaphylaxis " to "Anaphylaxis "

2017-03-10T15:45:25Z

Text replacement - "Anaphylaxis " to "Anaphylaxis "

← Older revision		Revision as of 15:45, 10 March 2017
Line 106:		Line 106:
	*Thrombocytopenia		*Thrombocytopenia
	*Leukopenia		*Leukopenia
	*Anaphylaxis		*[[Anaphylaxis]]
	*Angioedema		*Angioedema
	*Erythema Multiforme		*Erythema Multiforme